# ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill

> **NCT01317381** · — · UNKNOWN · sponsor: **University of Zurich** · enrollment: 100 (estimated)

## Conditions studied

- Critically Ill Patients

## Interventions

- **PROCEDURE:** Observational

## Key facts

- **NCT ID:** NCT01317381
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-05
- **Primary completion:** —
- **Final completion:** 2011-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01317381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01317381, "ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01317381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*